185 related articles for article (PubMed ID: 11741307)
1. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin.
Hosokawa M; Dolci W; Thorens B
Biochem Biophys Res Commun; 2001 Dec; 289(5):1114-7. PubMed ID: 11741307
[TBL] [Abstract][Full Text] [Related]
2. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
3. Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-D-glucose.
Wang Z; Gleichmann H
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():83-97. PubMed ID: 8839260
[TBL] [Abstract][Full Text] [Related]
4. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity.
Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662
[TBL] [Abstract][Full Text] [Related]
5. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
Jetton TL; Liang Y; Cincotta AH
Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
[TBL] [Abstract][Full Text] [Related]
7. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan.
Elsner M; Tiedge M; Guldbakke B; Munday R; Lenzen S
Diabetologia; 2002 Nov; 45(11):1542-9. PubMed ID: 12436338
[TBL] [Abstract][Full Text] [Related]
8. Insulin and GLUT2 glucose transporter immunoreactivity in B-cells of whole pancreas isografts and allografts in the streptozotocin-diabetic rat.
Jörns A; Klempnauer J
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():103-6. PubMed ID: 8839264
[TBL] [Abstract][Full Text] [Related]
9. Detrimental effect of protracted hyperglycaemia on beta-cell neogenesis in a mouse murine model of diabetes.
Guz Y; Torres A; Teitelman G
Diabetologia; 2002 Dec; 45(12):1689-96. PubMed ID: 12488958
[TBL] [Abstract][Full Text] [Related]
10. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
Wang Z; Gleichmann H
Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
[TBL] [Abstract][Full Text] [Related]
11. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin.
Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S
Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141
[TBL] [Abstract][Full Text] [Related]
12. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin.
Elsner M; Guldbakke B; Tiedge M; Munday R; Lenzen S
Diabetologia; 2000 Dec; 43(12):1528-33. PubMed ID: 11151762
[TBL] [Abstract][Full Text] [Related]
13. Glucose transporter-2 (GLUT2) promoter mediated transgenic insulin production reduces hyperglycemia in diabetic mice.
Burkhardt BR; Parker MJ; Zhang YC; Song S; Wasserfall CH; Atkinson MA
FEBS Lett; 2005 Oct; 579(25):5759-64. PubMed ID: 16223491
[TBL] [Abstract][Full Text] [Related]
14. Differential metabolite accumulation may be the cause of strain differences in sensitivity to streptozotocin-induced beta cell death in inbred mice.
Cardinal JW; Allan DJ; Cameron DP
Endocrinology; 1998 Jun; 139(6):2885-91. PubMed ID: 9607798
[TBL] [Abstract][Full Text] [Related]
15. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression.
De Vos A; Heimberg H; Quartier E; Huypens P; Bouwens L; Pipeleers D; Schuit F
J Clin Invest; 1995 Nov; 96(5):2489-95. PubMed ID: 7593639
[TBL] [Abstract][Full Text] [Related]
16. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
[TBL] [Abstract][Full Text] [Related]
17. c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injury.
Fukuda K; Tesch GH; Nikolic-Paterson DJ
Biochem Biophys Res Commun; 2008 Feb; 366(3):710-6. PubMed ID: 18082135
[TBL] [Abstract][Full Text] [Related]
18. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells.
Schnedl WJ; Ferber S; Johnson JH; Newgard CB
Diabetes; 1994 Nov; 43(11):1326-33. PubMed ID: 7926307
[TBL] [Abstract][Full Text] [Related]
19. Scoparia dulcis, a traditional antidiabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo.
Latha M; Pari L; Sitasawad S; Bhonde R
J Biochem Mol Toxicol; 2004; 18(5):261-72. PubMed ID: 15549711
[TBL] [Abstract][Full Text] [Related]
20. Betacellulin improves glucose metabolism by promoting conversion of intraislet precursor cells to beta-cells in streptozotocin-treated mice.
Li L; Seno M; Yamada H; Kojima I
Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E577-83. PubMed ID: 12900379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]